Wang On plans to invest mainland pharmaceutical business

Wang On (1222) said the company is in talks with the independent  third parties on investing mainland 

 pharmaceutical business. Relevant talks are on initial stage,  no agreement reached yet. At present directors of the company are not sure if the investment should be the dealings that must be disclosed. The company will make another announcement if necessary

Related stock : (1222)